91 – 100 of 120
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women : a cohort study
(
- Contribution to journal › Article
-
Mark
Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.
(
- Contribution to journal › Article
-
Mark
Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis
(
- Contribution to journal › Article
-
Mark
Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.
(
- Contribution to journal › Article
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.
(
- Contribution to journal › Article
- 2013
-
Mark
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
(
- Contribution to journal › Article
-
Mark
Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases
(
- Contribution to journal › Article
-
Mark
Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
(
- Contribution to journal › Article